Implantable Cardiac Device T-Wave Alternans Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting T-wave alternans patterns are cumbersome and inconvenient, requiring long-term surface ECG recordings and off-line analysis, making continuous monitoring difficult, especially for patients with implanted cardiac devices.
Innovation Solution
An implantable cardiac device is equipped with a method to predict arrhythmia complexity by tracking beat-by-beat alterations in intracardiac electrogram features, using equations to correct T-wave detection for heart rate and calculating percentage reversal points to identify arrhythmia risks, allowing for early prediction and optimization of antiarrhythmia therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If surface ECG recordings and off-line analysis are used to detect T-wave alternans patterns, then measurement precision is improved, but device complexity and ease of operation worsen due to cumbersome procedures
Solution Approach 1:
The implantable device performs T-wave alternans detection automatically using its own sensing and processing capabilities, eliminating the need for external surface ECG recordings and off-line analysis. The device self-monitors intracardiac electrograms and computes alternans metrics continuously without requiring external equipment or manual intervention.
Solution Approach 2:
The patent replaces the mechanical surface ECG recording system with an implantable electronic device that directly senses intracardiac electrograms. This substitution eliminates the need for external electrodes, cables, and offline processing equipment, enabling continuous automated monitoring while maintaining detection precision.
2Reliability
If long-term surface ECG recordings are performed to detect T-wave alternans, then reliability of arrhythmia prediction is improved, but loss of time and productivity worsen due to extended monitoring periods
Solution Approach 1:
The implantable device enables continuous T-wave alternans monitoring without interruption, continuously sensing intracardiac electrograms and computing alternans metrics in real-time. This continuous operation provides reliable arrhythmia prediction data without requiring extended offline recording periods, as the device operates continuously once implanted.
Solution Approach 2:
The device performs preliminary detection and computation of T-wave alternans patterns continuously in the background, so that when arrhythmia risk assessment is needed, the data is already available. This eliminates the need for extended monitoring periods preceding the assessment, as the useful action of detection has been continuously performed in advance.
3Ease of operation
If implantable devices are used for continuous monitoring, then ease of operation is improved, but device complexity increases
Solution Approach 1:
The implantable device leverages its existing multi-functionality for cardiac monitoring and therapy delivery to also perform T-wave alternans detection. By utilizing the device's existing electrogram sensing and processing capabilities, the patent adds alternans detection functionality without requiring entirely separate hardware, thus managing complexity while enabling continuous monitoring.
Solution Approach 2:
The patent combines T-wave alternans detection functionality with the existing implantable device operations. The alternans analysis is integrated into the device's normal electrogram processing workflow, merging multiple functions into a unified system that reduces overall complexity compared to having separate dedicated systems.
Data Source
AI summary
Embodiments of the present invention relate to implantable systems, and methods for use therein, that can detect T-wave alternans and analyze the detected alternans to provide information regarding cardiac instabilities and predict impending arrhythmias.